Related Experiment Videos
Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin
Summary
Researchers isolated poly(A) RNA from rat medullary thyroid carcinoma to identify cholecystokinin (CCK) precursor sequences. They determined the nucleotide sequence of rat preprocholecystokinin cDNA, revealing gene structure and transcriptional elements.
Area of Science:
- Molecular Biology
- Endocrinology
- Genetics
Background:
- Medullary thyroid carcinoma in rats exhibits high levels of immunoreactive cholecystokinin (CCK).
- Understanding the genetic basis of CCK production in tumors is crucial for cancer research.
Purpose of the Study:
- To isolate and characterize the complementary DNA (cDNA) encoding the precursor to cholecystokinin (CCK) in a rat medullary thyroid carcinoma.
- To analyze the structure of the rat preprocholecystokinin gene, including non-coding regions and potential regulatory elements.
Main Methods:
- Poly(A) RNA isolation from rat medullary thyroid carcinoma.
- Synthesis of double-stranded cDNA and insertion into pBR322 plasmid.
- Bacterial colony screening using a hybridization probe derived from porcine CCK-8 amino acid sequence.
- Nucleotide sequencing of the identified CCK cDNA.
Main Results:
- The nucleotide sequence of rat preprocholecystokinin cDNA was determined.
- The cDNA comprises 33 nucleotides (5'-noncoding), 345 nucleotides (coding for a 115-amino acid precursor), and 199 nucleotides (3'-noncoding).
- A putative transcriptional control sequence (TATA-like) and start site were identified upstream of the coding region. CCK mRNA is approximately 750 nucleotides long and similar in size across different rat tissues.
Conclusions:
- The study successfully cloned and sequenced the cDNA for rat preprocholecystokinin, providing insights into its precursor structure.
- Identification of potential transcriptional regulatory elements suggests mechanisms for CCK gene expression control.
- The findings contribute to understanding CCK gene expression in both normal tissues and thyroid carcinoma.